When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Biomarker testing in non-small cell lung cancer is underutilized, hindering optimal treatment. Streamlined processes and ...

A cancer diagnosis can turn life upside down for patients and their families. Providers say advancements in biomarker testing can potentially improving patient outcomes. Biomarker testing can reveal ...

The landscape of oncology is undergoing a transformative shift with the emergence of tumor-agnostic approaches, driven by the understanding that cancer treatment can transcend the traditional paradigm ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...

Despite the clinical utility of biomarker testing in patients with prostate cancer, the tests are infrequently ordered, preventing optimized care. Despite guideline recommendations and the efficacy of ...

Hummingbird Diagnostics GmbH, a pioneer in harnessing blood-based small RNAs for early disease detection and characterization, today announced the publication of a new study in Nature Communications ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...